Vor Biopharma Inc Earnings

The next earnings date for Vor Biopharma Inc is August 10, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Vor Biopharma Inc Earnings

Report Date	Estimated Earnings Per Share
08/10/2026	$-0.69

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Vor Biopharma Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
05/13/2026	Before Market	$-5.11	-548.31%
03/30/2026	Before Market	$25.84	1,625.29%
11/13/2025	After Market	$-3.33	-1.39%
08/12/2025	After Market	$-43.80	-394.60%
05/14/2025	After Market	$-5.20	-12.62%
03/20/2025	After Market	$-8.80	-52.48%
11/07/2024	After Market	$-8	1.46%
08/08/2024	After Market	$-8.20	2.83%
05/09/2024	After Market	$-9	-17.69%
03/20/2024	After Market	$-7.80	23.28%
11/07/2023	After Market	$-9.80	-3.54%
08/10/2023	After Market	$-9	-3.06%
05/11/2023	After Market	$-8.60	-11.12%
03/23/2023	After Market	$-10.40	14.55%
11/10/2022	After Market	$-12.60	-2.68%
08/11/2022	After Market	$-11.60	12.79%
05/12/2022	After Market	$-12.20	-17.76%
03/14/2022	After Market	$-9.60	15.99%
11/10/2021	After Market	$-10	20.47%
08/09/2021	After Market	$-10	1.48%
05/06/2021	After Market	$-13.40	-6.42%
03/25/2021	After Market	$-4,349.80	-4,797.72%

More About Vor Biopharma Inc

Website

https://www.vorbio.com

Country

USA

Full Time Employees

Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

“Vor Biopharma Inc Earnings” Can Refer to the Vor Biopharma Inc Earnings Date

Some people say “Vor Biopharma Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Vor Biopharma Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Vor Biopharma Inc Stock on the Earnings Date

If you own Vor Biopharma Inc stock (VOR) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Vor Biopharma Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Vor Biopharma Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Vor Biopharma Inc Earnings

You can contact us any time if you would like to ask questions about Vor Biopharma Inc earnings or anything else related to the stock market.